SUPN - Supernus Pharmaceuticals EPS beats by $0.16 misses on revenue August, 18 2020 04:58 PM Supernus Pharmaceuticals Inc. Supernus Pharmaceuticals (NASDAQ:SUPN): Q2 GAAP EPS of $0.65 beats by $0.16.More news on: Supernus Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...